Target intelligence / Profile preview

CROCC pseudogene 5 (CROCCP5)

Target
CROCCP5
Molecular classification
Pseudogene, Long noncoding RNA (lncRNA), Other
01

Overview

CROCCP5 is a pseudogene, meaning it is a non-functional sequence of genomic DNA originally derived from the functional CROCC (ciliary rootlet coiled-coil) gene, likely through duplication or retrotransposition. Pseudogenes generally do not encode functional proteins but may have regulatory roles in gene expression, especially in cancer. Some pseudogenes have been shown to act as competing endogenous RNAs (ceRNAs), affecting the regulation of other genes through miRNA sequestration networks, but direct evidence for CROCCP5 specifically is unavailable. There is no evidence that CROCCP5 is a protein, receptor, transporter, or any direct therapeutic target—it is a pseudogene and so would not fall into classic categories such as receptor, enzyme, transporter, or transcription factor. The major, functional gene in this family is CROCC (rootletin), which is a structural component of the ciliary rootlet, involved in centriole-centriole cohesion, cilium assembly, and protein localization to the cilium. However, CROCCP5 does not code for this protein and is instead a nonfunctional remnant. The entry is therefore "incorrect" as a molecular target in the conventional therapeutic sense.

Other names
ciliary rootlet coiled-coil pseudogene 5
02

Mechanism of action

None (for direct targeting)

03

Biological functions

No known protein-coding or enzymatic function. Like other pseudogenes, it may have potential regulatory roles as a competing endogenous RNA (ceRNA), influencing gene expression via miRNA sponging.
04

Disease associations

Pseudogenes have been implicated in cancer. Specific references to CROCCP5 and its involvement in diseases are lacking, but some pseudogenes are used as biomarkers in cancers such as colorectal cancer (CRC).
05

Safety considerations

None known
06

Biomarkers

Some pseudogenes have been suggested as biomarkers, particularly in cancer prognostic signatures, but CROCCP5 is not specifically listed among them.

Beyond the preview

Go deeper on CROCC pseudogene 5 (CROCCP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CROCC pseudogene 5 (CROCCP5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call